🔎 Trials Near Me

Home › Amyloidosis › Texas › Dallas

Amyloidosis clinical trials in Dallas, TX

9 studies for Amyloidosis are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

RecruitingObservational study
  • Research Site, Dallas
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

RecruitingPhase 3
  • Clinical Trial Site, Dallas
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

RecruitingPhase 3
  • Clinical Trial Site, Dallas
Ages 18 to 85 · All sexes · Updated Sep 15, 2026 · NCT07223203

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

RecruitingObservational study
  • Clinical Trial Site, Dallas
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07358078

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

RecruitingObservational study
  • University of Texas Southwestern Medical Center, Dallas
Ages 30 to 80 · All sexes · Updated Aug 31, 2026 · NCT05489549

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

RecruitingPhase 1/2
  • UT Southwestern Medical Center, Dallas
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05145816

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

RecruitingPhase 3
  • University of Texas Southwestern, Dallas
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

RecruitingPhase 3
  • Baylor Scott & White Research Institute, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

RecruitingObservational study
  • UT Southwestern Medical Center, Dallas
Ages 30 to 80 · All sexes · Updated Jan 7, 2026 · NCT07196839

About Amyloidosis

Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.

More about Amyloidosis on MedlinePlus

Amyloidosis trials in other cities

Other studies in Dallas

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.